GelStat Corporation (GSAC) Research

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.

Market snapshot

Symbol
GSAC
Price
$0.00
Day change
0.00%
Market cap
$123.6K
P/E ratio
-2.59x
52-week range
0.0002-0.0005
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aoxing Pharmaceutical Company, Inc. (AOXG)
  • Plant-Based Investment Corp. (CWWBF)
  • 4Front Ventures Corp. (FFNTF)
  • Grapefruit USA, Inc. (GPFT)
  • Link Reservations Inc. (LRSV)
  • Thoughtful Brands Inc. (PEMTF)
  • Pazoo, Inc. (PZOO)
  • Real Brands, Inc. (RLBD)

Recent insider activity

  • Goldfarb Adrian Graham — P-Purchase (53209459 shares) on 2022-02-04
  • Goldfarb Adrian Graham — P-Purchase (9843750 shares) on 2022-02-04
  • Goldfarb Adrian Graham — P-Purchase (8000000 shares) on 2022-02-04
  • Goldfarb Adrian Graham — P-Purchase (16000000 shares) on 2022-02-04
  • Goldfarb Adrian Graham — J-Other (2052600 shares) on 2012-12-31

Open GelStat Corporation (GSAC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.